OVARIAN CANCER METASTATIC RECURRENT

Clinical trials for OVARIAN CANCER METASTATIC RECURRENT explained in plain language.

Never miss a new study

Get alerted when new OVARIAN CANCER METASTATIC RECURRENT trials appear

Sign up with your email to follow new studies for OVARIAN CANCER METASTATIC RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New hope for ovarian cancer patients out of options

Disease control Not yet recruiting

This study is for people with recurrent ovarian cancer that has progressed after treatment with a specific type of maintenance therapy (PARP inhibitors). It aims to see if a newer, targeted drug called trastuzumab deruxtecan works better than standard chemotherapy. The drug speci…

Matched conditions: OVARIAN CANCER METASTATIC RECURRENT

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

OVARIAN CANCER METASTATIC RECURRENT

Get alerted when new OVARIAN CANCER METASTATIC RECURRENT trials appear

New hope for ovarian cancer patients out of options